Return to Article Details LOSS OF HETEROZYGOSITY AT THE BRCA1 LOCUS AS A MARKER OF SEN- SITIVITY FOR ADJUVANT CHEMOTHERAPY IN HEREDITARY OVARIAN CANCER Download Download PDF